PROSE, GLOBAL LEADER IN PERSONALIZATION, UNVEILS ITS AI-POWERED BEAUTYTECH PLATFORM
Singular, the only-of-its-kind BeautyTech platform behind Prose, drives personalized beauty to unprecedented scale, bringing forth a new model for the beauty industry NEW YORK, April 10, 2024 /PRNews
PR NewswireApr 10 09:15 ET
Singular Genomics Systems Is Maintained at Neutral by UBS
Singular Genomics Systems Is Maintained at Neutral by UBS
Dow JonesMar 21 15:01 ET
Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2023 Earnings Call Transcript
Yahoo FinanceMar 20 10:10 ET
Singular Genomics Faces Nasdaq Delisting: A Race Against Time to Meet Minimum Bid Price
TipRanksMar 20 02:00 ET
Q4 2023 Singular Genomics Systems Inc Earnings Call
Yahoo FinanceMar 19 06:19 ET
Earnings Call Summary | Singular Genomics(OMIC.US) Q4 2023 Earnings Conference
The following is a summary of the Singular Genomics Systems, Inc. (OMIC) Q4 2023 Earnings Call Transcript:Financial Performance:Unable to provide a summary as no financial performance details were pro
moomoo AIMar 18 19:14 ET · Conference Call
Singular Genomics Sys: Q4 Earnings Insights
Singular Genomics Sys (NASDAQ:OMIC) reported its Q4 earnings results on Monday, March 18, 2024 at 04:05 PM.Here's what investors need to know about the announcement.EarningsSingular Genomics Sys beat
BenzingaMar 18 16:40 ET
Singular Genomics Systems GAAP EPS of -$0.32 Beats by $0.02, Revenue of $1.1M Beats by $0.06M
Seeking AlphaMar 18 16:11 ET
Singular Genomics Systems 4Q Rev $1.08M >OMIC
Singular Genomics Systems 4Q Rev $1.08M >OMIC
Dow JonesMar 18 16:06 ET
Press Release: Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results
Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results SAN DIEGO, March 18, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a com
Dow JonesMar 18 16:05 ET
Earnings Scheduled For March 18, 2024
Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to report earnings for its fourth quarter. • System1 (NYSE:SST) is estimated to report quarterly loss at $0.33 per share on rev
BenzingaMar 18 05:57 ET
Preview: Singular Genomics Sys's Earnings
Singular Genomics Sys (NASDAQ:OMIC) is set to give its latest quarterly earnings report on Monday, 2024-03-18. Here's what investors need to know before the announcement.Analysts estimate that Singula
BenzingaMar 15 11:01 ET
Singular Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024
SAN DIEGO, March 04, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and
GlobeNewswireMar 4 16:05 ET
12 Health Care Stocks Moving In Friday's After-Market Session
GainersSingular Genomics Sys (NASDAQ:OMIC) shares moved upwards by 17.9% to $0.66 during Friday's after-market session. The market value of their outstanding shares is at $48.4 million. Vaccinex (NASD
BenzingaFeb 9 16:31 ET
Singular Genomics Showcases New G4X Spatial Sequencer At AGBT And Announces Significant Advances In Throughput, Quality, And Usability For G4 Sequencing Platform
Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, announced groundbr
BenzingaFeb 5 10:56 ET
Singular Genomics Systems Is Maintained at Neutral by Goldman Sachs
Singular Genomics Systems Is Maintained at Neutral by Goldman Sachs
Dow JonesJan 22 07:59 ET
Express News | Goldman Sachs Maintains Neutral on Singular Genomics Sys, Lowers Price Target to $0.85
Moomoo 24/7Jan 22 07:50 ET
Singular Genomics Sys Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/22/2024 101.9% Goldman Sachs $0.95 → $0.85 Maintains Neutral 08/10/2023 137.53% Goldman Sachs $1.15 → $
BenzingaJan 22 07:46 ET
Singular Genomics Reports Instrument Shipments, Preliminary Q4 Revenue
Seeking AlphaJan 8 02:17 ET
Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue
SAN DIEGO, Jan. 07, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians,
GlobeNewswireJan 7 17:00 ET
No Data
No Data